← Back to Stock Screener← Stock Screener

ZYBERNO

Stock Report

Updated Aug 24, 2026

GALAPAGOS NV (GLPGF)

Healthcare • OTC

$28.08

Professional Investment Analysis

ZYBERNO SCORE →

Is it a great business? Is it getting better?

34.0/100

WEAK BUSINESS

GALAPAGOS NV (GLPGF) scores 34/100 — weak fundamentals with mixed indicators requiring careful analysis before acting.

📊 How is the Zyberno Score calculated? +

The Zyberno Score answers one question: "Is this a quality business worth owning?" It's a 0-100 investment grade that evaluates business fundamentals across four critical dimensions, based on principles from Warren Buffett, Benjamin Graham, Peter Lynch, and Charlie Munger.

The 4 Core Categories (25 points each):

1. PROFITABILITY (25 pts)

Metrics: ROE, ROIC, Net Margin, Operating Margin
Thresholds: ROE >20% excellent • ROIC >20% excellent • Net Margin >20% excellent • Operating Margin >25% excellent

2. FINANCIAL STRENGTH (25 pts)

Metrics: Debt-to-Equity, Current Ratio, Interest Coverage, Altman Z-Score
Thresholds: D/E <0.3 excellent • Current Ratio >2.5 excellent • Interest Coverage >10x excellent • Altman Z >3.0 safe

3. CASH FLOW QUALITY (25 pts)

Metrics: Free Cash Flow, OCF vs Net Income, FCF Margin
Thresholds: Positive & growing FCF excellent • OCF/NI >1.2x excellent (cash earnings exceed accounting)

4. GROWTH & CONSISTENCY (25 pts)

Metrics: Revenue Growth, Net Income Growth, FCF Growth, Piotroski F-Score
Thresholds: Growth via log-linear regression • Piotroski 8-9 excellent, 6-7 good

Score Interpretation:

75-100

GREAT BUSINESS

65-74

GOOD BUSINESS

50-64

AVERAGE BUSINESS

30-49

WEAK BUSINESS

0-29

POOR BUSINESS

→ View full GLPGF quality analysis & detailed breakdown

VALUATION SIGNAL

MARGIN OF SAFETY

Is this stock cheap or expensive relative to what the business has historically generated for owners?

Margin of Safety unavailable — insufficient data for the owner-earnings DCF.

BRINA GAP ↗

Is the market underestimating or overestimating what this business is capable of going forward?

+6.9%

Slight Underestimate

💰 How is Margin of Safety calculated? +

Margin of Safety measures how much discount or premium you're paying relative to a stock's intrinsic value. It's Benjamin Graham's core principle: the larger the margin, the lower your downside risk.

Formula: (Intrinsic Value − Current Price) ÷ Intrinsic Value × 100%

How We Calculate Intrinsic Value (DCF Method):

Step 1: Calculate current Owner Earnings (OCF − Maintenance CapEx)

Step 2: Calculate company-specific growth rate using log-linear regression on 16 quarters of Owner Earnings

Step 3: Project 10 years forward using the calculated growth rate

Step 4: Discount each year's cash flow to present value using 10% discount rate

Step 5: Calculate terminal value using 3% perpetual growth rate

Step 6: Sum all discounted cash flows = Intrinsic Value

What The Percentages Mean:

+50% or more

EXCELLENT — Very undervalued

+25% to +50%

GOOD — Attractive discount

0% to +25%

FAIR — Reasonable value

0% to -25%

CAUTION — Slight premium

-25% or worse

POOR — Overvalued

"Price is what you pay, value is what you get." — Warren Buffett

→ View full GLPGF valuation analysis · → View full GLPGF Brina Gap analysis

📈 How is Brina Gap calculated? +

Brina Gap measures the difference between the growth a business can fundamentally sustain and the growth the market is already pricing in.

Formula: Fundamental Growth Rate − Market-Implied Growth Rate

The Two Components:

Fundamental Growth Rate = ROIC × Reinvestment Rate

What the business can sustainably grow at based on how much it reinvests and what return it earns on that capital. Grounded in historical financials.

Market-Implied Growth Rate = Reverse DCF

The growth rate the current Enterprise Value implicitly assumes. Calculated by back-solving a 10-year DCF model (10% WACC, 3% terminal growth) until the present value of projected cash flows equals EV.

What The Gap Means:

Gap > +5% Market Underestimates — potential upside

+2% to +5% Slight Underestimate

-2% to +2% Fairly Priced — market consensus matches fundamentals

-5% to -2% Slight Overestimate

Gap < -5% Market Overestimates — price embeds optimism fundamentals don't support

A positive gap (market underestimates) combined with a positive Margin of Safety is the strongest combined signal — the business is both cheap historically and forward economics are stronger than the price suggests.

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)

Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)

Operating Margin (Operational Efficiency):CRITICAL (0.0%)

Return on Capital (Capital Efficiency):POOR (6.9%)

📊 Valuation Trilogy

Three interconnected metrics for complete valuation analysis

Click any metric for full methodology and detailed analysis

Zyberno's Verdict

GALAPAGOS NV (GLPGF) stock report — Zyberno Score 34/100 (WEAK BUSINESS). Full financial analysis on Zyberno.

According to Zyberno's DCF model, GALAPAGOS NV (GLPGF) shows a Brina Gap of +6.9%, which strengthens the case: based on the company's ROIC (6.9%) and reinvestment rate (-2.3%), the business can fundamentally grow at -0.2% — but the current enterprise value implies the market expects -7.1%.

DIVISION I: EXECUTIVE SUMMARY

A. Market Valuation

Market Price & Capitalization (2)

Current Price:28.08

Market Cap:$1.85B

Valuation Multiples (2)

P/B Ratio:0.49x

Peg Ratio:-999.00x

Enterprise Metrics (2)

Enterprise Value:$1.81B

Ev Ebitda Ratio:4.99x

Price Action & Momentum (1)

% of 52-Week High:103.5%

B. Profitability Assessment

Return Metrics (5)

Roic:

6.9%

📊 Click to view full GLPGF ROIC analysis →

Reinvestment Rate:-2.3%

Fundamental Growth Rate (g):-0.2%

Market-Implied Growth Rate:-7.1%

Brina Gap:

6.9%

☷ Click to view full GLPGF Brina Gap analysis →

Margin Analysis (1)

Ebitda Margin:28.2%

Yield Metrics (2)

Earnings Yield:-$999.00

Dividend Yield:0.0%

C. Log-Linear Regression Growth Trends

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):44.3%

D. Financial Stability

Liquidity Ratios (3)

Current Ratio:20.15x

Quick Ratio:20.00x

Cash Ratio:0.23x

Leverage Analysis (3)

Debt To Equity Ttm:0.00x

Debt-to-Equity Ratio:0.00x

Debt To Ebitda:0.00x

Coverage Ratios (2)

Interest Coverage Ratio:285.34x

Times Interest Earned:285.34

Capital Structure (4)

Working Capital:3,381,386,707.60

Cash And Cash Equivalents:40,000,000.00

Long Term Debt:$0.00

Net Debt:-$40.00M

DIVISION II: FINANCIAL STATEMENTS ANALYSIS

A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $1.29B

Linear Growth: 44.3%

📊 Click to view full GLPGF Revenue analysis & methodology →

Cost Of Revenue Ttm:$34.36M

Profitability Breakdown (2)

$0.00$340.89M

Bottom Line Performance (3)

$370.75M

Income Before Tax:$0.00

Ebitda Ttm:362,473,243.40

Operating Expenses (5)

Operating Expenses:0.00

R And D Expense:0.00

Sga Expense:0.00

Income Tax Expense:-$139.80K

Interest Expense:1,194,683.60

Expense Ratios (3)

R And D To Revenue Percentage:0.0%

Sga To Revenue Percentage:0.0%

Ebitda Margin:28.2%

B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$3.94B

Current Assets:$3.56B

Ppe Net:83,126,408.40

Goodwill:80,889,554.00

Intangible Assets:$979.78K

Liability Structure (4)

Total Liabilities:197,169,010.00

Current Liabilities:176,617,910.20

Long Term Debt:$0.00

Short Term Debt:$0.00

Equity & Capital (3)

Equity:$3.74B

Retained Earnings:$0.00

Common Stock:0.00

Working Capital Items (3)

Accounts Receivable:23,923,712.40

Inventory:25,988,412.20

Accounts Payable:120,909,143.80

Special Items (2)

Contract Liabilities:0.00

Stock Based Compensation:0.00

C. Cash Flow Analysis

Operating Activities (2)

-$297.46M-$313.30M

Investment Activities (1)

Investing Cash Flow:$333.70M

Financing Activities (3)

Financing Cash Flow:-$3.78M

Dividends Paid Ttm:0.00

Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00

Long Term Debt Issuance:$0.00

Long Term Debt Repayments:$0.00

DIVISION III: OPERATIONAL METRICS

A. Per Share Analysis

Earnings Per Share (1)

Earnings Per Share Ttm:$5.63

Revenue & Cash Per Share (2)

Sales Per Share Ttm:19.50

Operating Cash Flow Per Share:-$4.51

Book Value & Capital (2)

Book Value Per Share:$56.74

Cash Per Share:0.61

Dividend Policy (1)

Dividend Payout Ratio:-999.00x

B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.33x

Working Capital Turnover Ttm:0.38x

Receivables Management (2)

Receivables Turnover Ttm:53.72x

Days Sales Outstanding Ttm:6.79

Inventory Management (2)

Inventory Turnover Ttm:1.32x

Days Inventory Outstanding Ttm:276.09

Payables & Cash Cycle (2)

Days Payable Outstanding:1,284.51

Cash Conversion Cycle:-1,001.62

C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00

Quality Score:70.00

Market Metrics (2)

Beta:0.00x

Volatility Category:unknown

DIVISION IV: INVESTMENT ANALYSIS

A. Value Investment Framework

Damodaran Growth Analysis (4)

Reinvestment Rate:-2.3%

Fundamental Growth Rate (g):-0.2%

Market-Implied Growth Rate:-7.1%

Brina Gap:

6.9%

☷ Click to view full GLPGF Brina Gap analysis →

B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):44.3%

C. Company Profile & Context

Corporate Information (6)

Symbol:GLPGF

Company Name:GALAPAGOS NV

Sector:Healthcare

Industry:Pharmaceuticals

Exchange:OTC

Country:Unknown

Market Classification (3)

Market Cap Category:N/A

Price Category:medium

Volume Category:N/A

Share Structure (3)

Shares Outstanding:65.90M

Shares Outstanding Basic:0

Shares Outstanding Diluted:0

Data Processing Info (3)

Processing Version:v3.0

Last Updated:2026-08-24 05:28:49 UTC

Data Timestamp:2026-08-24T05:28:49.499214